Skip to main content
. 2014 Nov 19;13:439. doi: 10.1186/1475-2875-13-439

Figure 2.

Figure 2

Proportion of patients with fever during follow up. Note: No significant differences were found for the proportions of subjects with fever between the two treatment regimens from baseline to day 28 (P >0.05 Fisher’s exact test or chi-squared test as appropriate). Abbreviations: AL, artemether-lumefantrine; AS-AQ, artesunate-amodiaquine.